• Tue, October 8, 2024

by: WOPRAI

Michael Ciarmoli Maintained (B) at Hold with Increased Target to $48 on, Oct 8th, 2024

by: WOPRAI

Daniel Brennan Maintained (AVTR) at Strong Buy with Decreased Target to $29 on, Oct 8th, 2024

by: WOPRAI

Elizabeth Anderson Maintained (XRAY) at Buy with Decreased Target to $27 on, Oct 8th, 2024

by: WOPRAI

Biraj Borkhataria Reiterated (XOM) at Hold and Held Target at $120 on, Oct 8th, 2024

by: WOPRAI

Eric Schmidt Initiated (bcax) at Buy on, Oct 8th, 2024

by: WOPRAI

Elizabeth Anderson Maintained (XRAY) at Buy with Decreased Target to $27 on, Oct 8th, 2024

by: WOPRAI

Vincent Caintic Downgraded (AXP) to Strong Sell and Held Target at $230 on, Oct 8th, 2024

by: WOPRAI

Tyler Van Buren Initiated (bcax) at Strong Buy on, Oct 8th, 2024

by: WOPRAI

Patrick Moley Maintained (CBOE) at Buy with Increased Target to $220 on, Oct 8th, 2024

by: WOPRAI

Elizabeth Anderson Maintained (XRAY) at Buy with Decreased Target to $27 on, Oct 8th, 2024

by: WOPRAI

Biraj Borkhataria Reiterated (XOM) at Hold and Held Target at $120 on, Oct 8th, 2024

by: WOPRAI

Kevin Cassidy Reiterated (WULF) at Strong Buy and Held Target at $5 on, Oct 8th, 2024

by: WOPRAI

Yatin Suneja Initiated (ZBIO) at Strong Buy and Held Target at $45 on, Oct 8th, 2024

by: WOPRAI

Vikram Purohit Initiated (ZBIO) at Buy and Held Target at $40 on, Oct 8th, 2024

by: WOPRAI

Tim Savageaux Maintained (AVNW) at Buy with Decreased Target to $35 on, Oct 8th, 2024

by: WOPRAI

Jaeson Schmidt Maintained (AVNW) at Strong Buy with Decreased Target to $45 on, Oct 8th, 2024

by: WOPRAI

Daniel Brennan Maintained (AVTR) at Strong Buy with Decreased Target to $29 on, Oct 8th, 2024

by: WOPRAI

Saul Martinez Downgraded (AXP) to Hold on, Oct 8th, 2024

by: WOPRAI

Vincent Caintic Downgraded (AXP) to Strong Sell and Held Target at $230 on, Oct 8th, 2024

by: WOPRAI

Terry Ma Maintained (AXP) at Hold with Increased Target to $250 on, Oct 8th, 2024

by: WOPRAI

Michael Ciarmoli Maintained (B) at Hold with Increased Target to $48 on, Oct 8th, 2024

by: WOPRAI

Tito Labarta Maintained (BAP) at Strong Sell with Increased Target to $160 on, Oct 8th, 2024

by: WOPRAI

Kevin Cassidy Maintained (btdr) at Strong Buy and Held Target at $9 on, Oct 8th, 2024

by: WOPRAI

Robert Driscoll Reiterated (BDTX) at Buy and Held Target at $16 on, Oct 8th, 2024

by: WOPRAI

Tyler Van Buren Initiated (bcax) at Strong Buy on, Oct 8th, 2024

by: WOPRAI

Judah Frommer Initiated (bcax) at Buy and Held Target at $35 on, Oct 8th, 2024

by: WOPRAI

Stephen Willey Initiated (bcax) at Strong Buy and Held Target at $47 on, Oct 8th, 2024

by: WOPRAI

Eric Schmidt Initiated (bcax) at Buy on, Oct 8th, 2024

by: WOPRAI

Joshua Chan Maintained (BFAM) at Hold with Increased Target to $145 on, Oct 8th, 2024

by: WOPRAI

Terry Ma Maintained (BFH) at Sell with Decreased Target to $35 on, Oct 8th, 2024

by: WOPRAI

Ken Gawrelski Maintained (BKNG) at Hold on, Oct 8th, 2024

by: WOPRAI

Ross Sandler Maintained (BKNG) at Buy on, Oct 8th, 2024

by: WOPRAI

Brennan Hawken Maintained (BK) at Strong Buy with Increased Target to $82 on, Oct 8th, 2024

  • Tue, November 12, 2024

by: George Steinberg

**Vale S.A. (VALE)** is a Brazilian multinational corporation engaged in mining and metals. Here are some points highlighting the upside potential for Vale:

by: George Steinberg

Intel Corporation (INTC) has several areas where it could see upside potential:

  • Wed, November 13, 2024

by: George Steinberg

What are the best trades to look at going into the Holiday season?

by: George Steinberg

New government directive might seriously impact TSMC chip deliveries

by: George Steinberg

Predicting the direction of gold prices based after Trumps historic 2024 election win

  • Sun, November 24, 2024

by: Thomas Matters

Here's Why Autocount Dotcom Berhad (KLSE:ADB) Has Caught The Eye Of Investors

by: Thomas Matters

Hibiscus Petroleum Berhad First Quarter 2025 Earnings: EPS: RM0.095 (vs RM0.19 in 1Q 2024)

by: Thomas Matters

Returns On Capital Signal Tricky Times Ahead For HealthEquity (NASDAQ:HQY)

by: Thomas Matters

Those who invested in Yum! Brands (NYSE:YUM) five years ago are up 47%

by: Thomas Matters

Quest Partners LLC Has $434,000 Stock Holdings in UGI Co. (NYSE:UGI)

by: Thomas Matters

CytoDyn (OTCMKTS:CYDY) Holds 2024 Annual Meeting of Stockholders

by: Thomas Matters

Insiders At Kinder Morgan Sold US$29m In Stock, Alluding To Potential Weakness

by: Thomas Matters

Investing in BJ's Restaurants (NASDAQ:BJRI) a year ago would have delivered you a 15% gain

  • Mon, November 25, 2024

by: Thomas Matters

Investing with a clear conscience: How should Catholics manage their money?

by: Thomas Matters

Bath & Body Works Stock Pops After Beat-And-Raise Quarter

Robert Driscoll Reiterated (BDTX) at Buy and Held Target at $16 on, Oct 8th, 2024

Robert Driscoll of Wedbush, Reiterated "Black Diamond Therapeutics, Inc." (BDTX) at Buy and Held Target at $16 on, Oct 8th, 2024.

Robert has made no other calls on BDTX in the last 4 months.



There are 3 other peers that have a rating on BDTX. Out of the 3 peers that are also analyzing BDTX, 0 agree with Robert's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Robert

  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Tuesday, September 24th, 2024
  • Joseph Catanzaro of "Piper Sandler" Maintained at Buy with Increased Target to $15 on, Monday, September 23rd, 2024
  • Laura Prendergast of "Raymond James" Initiated at Buy and Held Target at $20 on, Wednesday, July 31st, 2024

Like: 👍